Zacks Research Has Negative Estimate for Amgen Q1 Earnings

Amgen Inc. (NASDAQ:AMGN – Free Report) – Research analysts at Zacks Research decreased their Q1 2025 EPS estimates for shares of Amgen in a research note issued on Tuesday, February 25th. Zacks Research analyst R. Department now expects that the medical research company will post earnings of $4.17 per share for the quarter, down from […]

Leave a Reply

Your email address will not be published.

Previous post LightPath Technologies, Inc. (NASDAQ:LPTH) Sees Large Growth in Short Interest
Next post Air France-KLM (AFLYY) & Its Rivals Critical Survey